MITIGARE Trademark

Trademark Overview

On Tuesday, March 18, 2014, a trademark application was filed for MITIGARE with the United States Patent and Trademark Office. The USPTO has given the MITIGARE trademark a serial number of 86224548. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 17, 2020. This trademark is owned by West-Ward Pharmaceutical Corp.. The MITIGARE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of gout
mitigare

General Information

Serial Number86224548
Word MarkMITIGARE
Filing DateTuesday, March 18, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 17, 2020
Registration Number4761409
Registration DateTuesday, June 23, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 29, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of gout

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 2, 2014
Primary Code005
First Use Anywhere DateMonday, September 29, 2014
First Use In Commerce DateFriday, October 3, 2014

Trademark Owner History

Party NameHIKMA PHARMACEUTICALS USA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922
Party NameWest-Ward Pharmaceutical Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEatontown, NJ 07724
Party NameWest-Ward Pharmaceutical Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEatontown, NJ 07724
Party NameWest-Ward Pharmaceutical Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEatontown, NJ 07724

Trademark Events

Event DateEvent Description
Friday, March 21, 2014NEW APPLICATION ENTERED
Wednesday, April 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 20, 2014ASSIGNED TO EXAMINER
Saturday, June 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 29, 2014PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 20, 2015TEAS STATEMENT OF USE RECEIVED
Friday, March 20, 2015USE AMENDMENT FILED
Thursday, April 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 24, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 24, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, May 18, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 19, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 23, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, June 27, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 4, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 23, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 26, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 26, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 6, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 15, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 17, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 17, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, June 23, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, August 27, 2024TEAS SECTION 8 & 9 RECEIVED

Related Keywords

mitigare gout treatment preparation pharmaceutical